Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for- service insurance

Archives of Internal Medicine

Volumn 159, Issue 17, 1999, Pages 2013-2020

  Soumerai, Stephen B ^a   McLaughlin, Thomas J ^a   Gurwitz, Jerry H ^b   Pearson, Steven ^a   Christiansen, Cindy L ^a   Borbas, Catherine ^c   Morris, Nora ^c   McLaughlin, Barbara ^c   Gao, Xiaoming ^a   Ross Degnan, Dennis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Hlthcare Educ and Res Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; AGED; AMBULANCE; ARTICLE; COMMUNITY HOSPITAL; CONSULTATION; CONTROLLED STUDY; ELDERLY CARE; ELECTROCARDIOGRAM; EMERGENCY TREATMENT; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICAL RECORD; PATIENT TRANSPORT; PRIORITY JOURNAL; URBAN AREA;

ADRENERGIC BETA-ANTAGONISTS; AGED; ASPIRIN; ELECTROCARDIOGRAPHY; EMERGENCY TREATMENT; FEE-FOR-SERVICE PLANS; FEMALE; FIBRINOLYTIC AGENTS; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MEDICARE; MINNESOTA; MYOCARDIAL INFARCTION; PATIENT TRANSFER; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 0033610240     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.17.2013     Document Type: Article

References (39)

1. Medicare and Managed Care. Menlo Park, Calif: Henry Kaiser Family Foundation; 1997.
2. Davis K. Assuring Quality, Information, and Choice in Managed Care. New York, NY: Commonwealth Fund; 1997.
3. Kassirer JP. Access to specially care. N Engl J Med. 1994;331:1151-1153.
4. DeMaria AN, Engle MA, Marrison DC, et al. Managed care involvement by cardiovascular specialists: prevalence, attitudes and influence on practice. J Am Coll Cardiol. 1994;23:1245-1253.
5. Miller RH, Luft HS. Does managed care lead to better or worse quality of care? Health Aff (Millwood). September-October 1997;16:7-25.
6. Miller RH, Luft HS. Managed care plan performance since 1980: a literature analysis. JAMA. 1994;271:1512-1519.
7. Gold MR, Hurley R, Lake T, Ensor T, Berenson R. A national survey of the arrangements managed-care plans make with physicians. N Engl J Med. 1995; 333:1678-1683.
8. Beers MH, Fingold SF, Ouslander JG, Reuben DB, Morgenstern H, Beck JC. Characteristics and quality of prescribing by doctors practicing in nursing homes. J Am Geriatr Soc. 1993;41:802-807.
9. Stolley PD, Becker MH, Lasagna L, McEvilla JD, Sloane LM. The relationship between physician characteristics and prescribing appropriateness. Med Care. January-February 1972;10:17-28.
10. Kapantais G, Powell-Griner E. Characteristics of Persons Dying of Diseases of the Heart: Preliminary Data From the 1986 National Mortality Followback Survey. Hyattsville, Md: National Center for Health Statistics; 1989. Advance Data From Vital and Health Statistics, No. 172.
11. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction. Lancet. 1988;2:349-360.
12. The Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA. 1982;247:1707-1714.
13. Hjalmarson A, Herlitz J, Holmberg S, et al. The Goteborg Metoprolol Trial: effects on mortality and morbidity in acute myocardial infarction. Circulation. 1983; 67(6 pt 2):126-132.
14. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction. Lancet. 1986;2:57-66.
15. The Metoprolol in Acute Myocardial Infarction (MIAMI) Trial Research Group. A randomised placebo-controlled international trial. Eur Heart J. 1985;6:199-226.
16. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981; 304:801-807.
17. National Heart Attack Alert Program Coordinating Committee 60 Minutes to Treatment Working Group. Emergency department: rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med. 1994;23: 311-329.
18. Gurwitz JH, McLaughlin TJ, Willison DJ, et al. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med. 1997;126: 593-599.
19. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly. Arch Intern Med. 1996;156:799-805.
20. McLaughlin TJ, Soumerai SB, Willison DJ, et al. The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med. 1997;12:1-6.
21. Soumerai SB, McLaughlin TJ, Gurwitz JH, et al. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial. JAMA. 1998;279:1358-1363.
22. Gunnar RM, Passamani ER, Bourdillon PD, et al. Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 1990;16:249-292.
23. Willison DJ, Soumerai SB, McLaughlin TJ, et al. Consultation between cardiologists and generalists in the management of acute myocardial infarction. Arch Intern Med. 1998;158:1778-1783.
24. American Medical Association Directory of Physicians in the United States. 35th ed. Chicago, III: American Medical Association; 1996.
25. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? analysis using instrumental variables. JAMA. 1994;272:859-866.
26. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: comorbidity and outcomes after hip replacement. Med Care. 1993;31:141-154.
27. Morgan RO, Virnig BA, DeVito CA, Persily NA. The Medicare-HMO revolving door -the healthy go in and the sick go out. N Engl J Med. 1997;337:169-175.
28. Lichtenstein R, Thomas JW, Adams-Watson J, Lepkowski J, Simone B. Selection bias in TEFRA at-risk HMOs. Med Care. 1991;29:318-331.
29. Pashos CL, Normand SL, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol. 1994;23:1023-1030.
30. Hamburg RS, Ballin SD. Congress moves to address emergency cardiac care issues. Circulation. 1995;92:149-151.
31. Kerr HD. Access to emergency departments: a survey of HMO policies. Ann Emerg Med. 1989;18:274-277.
32. Stauffer M. Issue Brief: Emergency Care. Washington, DC: Health Policy Tracking Service, National Conference of State Legislatures; 1998.
33. Annas GJ. A national bill of patients' rights. N Engl J Med. 1998;338:695-699.
34. Gray BH. Trust and trustworthy care in the managed care era. Health Aff (Millwood). September-October 1997;16:34-49.
35. Seidman JJ, Bass EP, Rubin HR. Review of studies that compare the quality of cardiovascular care in HMO versus non-HMO settings. Med Care. 1998;36:1607-1625
36. Braveman P, Schaaf VM, Egerter S, Bennett T, Schecter W. Insurance-related differences in the risk of ruptured appendix. N Engl J Med. 1994;331:444-449.
37. Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care for Medicare patients with acute myocardial infarction: a four-state pilot study from the Cooperative Cardiovascular Project. JAMA. 1995;273:1509-1514.
38. The State of Managed Care Quality. Washington, DC: National Committee for Quality Assurance; 1997.
39. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994; 308:81-106.